Loading...

PODCAST

BiotechTV - News

This is the primary news channel of BiotechTV where you will find on the ground reporting by our journalists from biotech hubs throughout the world.

science life sciences

All Episodes

00:15:52

Jones Healthcare & Technology Innovation Conference:...

BiotechTV - News ·

2025/04/09

Brad Sitko describes how XOMA is able to do smaller deals than other larger investors in this space, and he gives examples of investments they have made. Plus how to help with the "zombie biotech" problem in some corners of the sector.

en-us

00:11:14

Jones Healthcare & Technology Innovation Conference:...

BiotechTV - News ·

2025/04/09

She describes how the mechanism of Haduvio differs from other programs in chronic cough, and covers the recent phase 2a RIVER data.

en-us

00:10:25

Jones Healthcare & Technology Innovation Conference:...

BiotechTV - News ·

2025/04/09

They discusses the macro and regulatory factors that have affected the sector so strongly, and comment on Wave, Korro, ProQr, Capricor, Trevi, and Kalvista.

en-us

00:16:02

Analyst Thursdays: Stifel's Alex Thompson updates us...

BiotechTV - News ·

2025/04/03

He shares his take on biotech and discusses argenx, Immunovant, AnaptysBio, Apogee, Dianthus, and Viridian.

en-us

00:05:21

Anglo Nordic Life Science Conference: The CEO of Cure...

BiotechTV - News ·

2025/04/03

CEO Helen Matthews describes the types of medicines they are supporting for clinical trials (including Ambroxol and GLP-1s), and folding a few programs into a dynamic, international consortium.

en-us

00:08:56

Anglo Nordic Life Science Conference: Denmark based...

BiotechTV - News ·

2025/04/03

Co-Founder and CEO Thomas Kledal describes the science behind this platform and program. Plus, how having access to donated kidneys is helping the company with its translational work.

en-us

00:12:59

On the heels of raising a $65M series B, the CEO of...

BiotechTV - News ·

2025/04/03

CEO Jason Gardner describes Ampersand's platform that is designed to make medicines act at the site of disease. He also shares updates on partnerships with Pfizer and Pioneering Medicines, and highlights work in obesity, immuno-inflammation and immuno-oncology.

en-us

00:10:41

BioTrinity 2025: With a novel E3 ubiquitin ligase...

BiotechTV - News ·

2025/04/02

CEO Nicki Thompson describes why she believes the company is differentied in the field, and how TRIMTECH's construct is designed to selectively degrade aggregates that cause neurodegeneration.

en-us

00:10:00

Vida Ventures named Matt Cohen and Brian Goodman new...

BiotechTV - News ·

2025/04/02

He describes his background in life sciences investing and shares his take on the current state of the sector.

en-us

00:14:06

After a $93M series B, Character Bio's CEO Cheng...

BiotechTV - News ·

2025/04/02

He describes why a 'one-size-fits-all' approach has caused numerous ophthalmology trials to fail in the past, and why Character believes a precision medicine approach is overdue.

en-us

00:12:07

BioTrinity 2025: AlveoGene Executive Chair David...

BiotechTV - News ·

2025/04/01

He describes the science behind the platform, which is already being used by Boehringer Ingelheim for cystic fibrosis. AlveoGene has plans to use it for conditions like the surfactant protein deficiencies SP-B & ABCA3, alpha-1 antitrypsin deficiency, and IPF.

en-us

00:14:06

Miami based Galatea Bio raised $25M today to expand...

BiotechTV - News ·

2025/03/27

Founder and CEO Carlos Bustamante tells BiotechTV's AI Correspondent, Ryan Flinn, about the biobank and why it is important to better understand how diseases can have different profiles across diverse populations. Plus, how AI will play a role in this work.

en-us

00:11:00

State of Possible: Winner of the MassBioDrive Startup...

BiotechTV - News ·

2025/03/27

Mari Anne Snow describes the advantages she sees nanoparticles having over current modalities like viral vectors, LNPs, and others.

en-us

00:04:02

State of Possible: Atlas Venture's Bruce Booth shares...

BiotechTV - News ·

2025/03/26

He describes the 14th fund that Atlas raised at the end of last year, which was $450 million. Plus, his take on the environment, regulatory changes, China's impact on the sector, and improving biopharma's image.

en-us

00:07:47

State of Possible: On the one-year anniversary of the...

BiotechTV - News ·

2025/03/26

She describes the idea of leveraging Glyph to achieve oral dosing of medicines in cases where it would not be possible or tolerable. Plus, the lead clinical program, allopregnanolone, how the company thinks about avoiding high placebo responses in trials, and other programs.

en-us

00:12:51

State of Possible: Beam Therapeutics' CEO John Evans...

BiotechTV - News ·

2025/03/26

He describes the nine patient dose ascending data in AAT deficiency that was historic for being the industry's first in-vivo proof of concept of a gene editor. Plus, what's next for that program and sickle cell, and the decision to do an "over the wall" financing.

en-us

00:13:16

State of Possible: Cigall Kadoch discusses her...

BiotechTV - News ·

2025/03/26

She describes the science behind chromatin and gene regulation, previews upcoming preclinical data the company will have at AACR for its lead SMARCA2 program (partnered with Lilly), and discusses what she would like to see out of future phase 1 data.

en-us

00:11:50

State of Possible: Kymera Therapeutics Founder and...

BiotechTV - News ·

2025/03/26

He gives a brief overview of this approach, comments on recent competitor data in cancer, and highlights Kymera's STAT6 and TYK2 programs.

en-us

00:06:11

State of Possible: Massachusetts Governor Maura...

BiotechTV - News ·

2025/03/26

She describes the efforts that government is making to support medical research in the area, shares her thoughts on competition in science and for jobs from China, and her thoughts on how the industry can improve its messaging.

en-us

00:13:25

State of Possible: Strand Therapeutics' Co-Founder &...

BiotechTV - News ·

2025/03/26

He describes the intratumoral IL-12 program that is in the clinic today, and the preclinical progress Strand is making on its other programs. Plus, his thoughts on the current public perception of mRNA.

en-us

486 results

Similar Podcasts

Astounding Stories 10

Ray Cummings

Das Wissen | SWR

SWR

Rabbit Hole of Research

Jotham Austin, II PhD, Nick Elizalde,...

תל אביב 360 – ערוץ הפודקסטים של אוניברסיטת תל אביב

Tel Aviv University

2026 Nuestro Oxígeno 10- Octubre

Nuestro Oxígeno